These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 26707830)

  • 1. Association of TIMP3 expression with vessel density, macrophage infiltration and prognosis in human malignant melanoma.
    Das AM; Koljenović S; Oude Ophuis CM; van der Klok T; Galjart B; Nigg AL; van Cappellen WA; Noordhoek Hegt V; Dinjens WN; Atmodimedjo PN; Vermeulen CE; Verhoef C; Eggermont AM; ten Hagen TL
    Eur J Cancer; 2016 Jan; 53():135-43. PubMed ID: 26707830
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tissue inhibitor of metalloproteinase-3 (TIMP3) expression decreases during melanoma progression and inhibits melanoma cell migration.
    Das AM; Bolkestein M; van der Klok T; Oude Ophuis CM; Vermeulen CE; Rens JA; Dinjens WN; Atmodimedjo PN; Verhoef C; Koljenović S; Smits R; Ten Hagen TL; Eggermont AM
    Eur J Cancer; 2016 Oct; 66():34-46. PubMed ID: 27522248
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Promoter methylation of TIMP3 and CDH1 predicts better outcome in head and neck squamous cell carcinoma treated by radiotherapy only.
    De Schutter H; Geeraerts H; Verbeken E; Nuyts S
    Oncol Rep; 2009 Feb; 21(2):507-13. PubMed ID: 19148529
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Promoter methylation and expression of TIMP3 gene in gastric cancer.
    Guan Z; Zhang J; Song S; Dai D
    Diagn Pathol; 2013 Jul; 8():110. PubMed ID: 23819566
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic significance of MGMT gene promoter methylation in differently treated metastatic melanomas.
    Cesinaro AM; Sartori G; Migaldi M; Schirosi L; Pellacani G; Collina G; Maiorana A
    Pathology; 2012 Jun; 44(4):313-7. PubMed ID: 22544212
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Loss of expression of TIMP3 in clear cell renal cell carcinoma.
    Masson D; Rioux-Leclercq N; Fergelot P; Jouan F; Mottier S; Théoleyre S; Bach-Ngohou K; Patard JJ; Denis MG
    Eur J Cancer; 2010 May; 46(8):1430-7. PubMed ID: 20194016
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differential TIMP3 expression affects tumor progression and angiogenesis in melanomas through regulation of directionally persistent endothelial cell migration.
    Das AM; Seynhaeve AL; Rens JA; Vermeulen CE; Koning GA; Eggermont AM; Ten Hagen TL
    Angiogenesis; 2014 Jan; 17(1):163-77. PubMed ID: 24221409
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic significance of ALCAM (CD166/MEMD) expression in cutaneous melanoma patients.
    Donizy P; Zietek M; Halon A; Leskiewicz M; Kozyra C; Matkowski R
    Diagn Pathol; 2015 Jul; 10():86. PubMed ID: 26134500
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Promoter hypermethylation contributes to TIMP3 down-regulation in high stage endometrioid endometrial carcinomas.
    Catasus L; Pons C; Muñoz J; Espinosa I; Prat J
    Histopathology; 2013 Mar; 62(4):632-41. PubMed ID: 23379820
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Objective assessment of blood and lymphatic vessel invasion and association with macrophage infiltration in cutaneous melanoma.
    Storr SJ; Safuan S; Mitra A; Elliott F; Walker C; Vasko MJ; Ho B; Cook M; Mohammed RA; Patel PM; Ellis IO; Newton-Bishop JA; Martin SG
    Mod Pathol; 2012 Apr; 25(4):493-504. PubMed ID: 22080065
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Down-regulation and promoter methylation of tissue inhibitor of metalloproteinase 3 in choriocarcinoma.
    Feng H; Cheung AN; Xue WC; Wang Y; Wang X; Fu S; Wang Q; Ngan HY; Tsao SW
    Gynecol Oncol; 2004 Aug; 94(2):375-82. PubMed ID: 15297175
    [TBL] [Abstract][Full Text] [Related]  

  • 12. TIMP3 expression associates with prognosis in colorectal cancer and its novel arylsulfonamide inducer, MPT0B390, inhibits tumor growth, metastasis and angiogenesis.
    Huang HL; Liu YM; Sung TY; Huang TC; Cheng YW; Liou JP; Pan SL
    Theranostics; 2019; 9(22):6676-6689. PubMed ID: 31588243
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Aberrant DNA methylation is associated with aggressive clinicopathological features and poor survival in cutaneous melanoma.
    de Unamuno Bustos B; Murria Estal R; Pérez Simó G; Simarro Farinos J; Pujol Marco C; Navarro Mira M; Alegre de Miquel V; Ballester Sánchez R; Sabater Marco V; Llavador Ros M; Palanca Suela S; Botella Estrada R
    Br J Dermatol; 2018 Aug; 179(2):394-404. PubMed ID: 29278418
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Paucity of tumor-infiltrating lymphocytes is an unfavorable prognosticator and predicts lymph node metastases in cutaneous melanoma patients.
    Donizy P; Kaczorowski M; Halon A; Leskiewicz M; Kozyra C; Matkowski R
    Anticancer Res; 2015 Jan; 35(1):351-8. PubMed ID: 25550571
    [TBL] [Abstract][Full Text] [Related]  

  • 15. TIMP3 regulates migration, invasion and in vivo tumorigenicity of thyroid tumor cells.
    Anania MC; Sensi M; Radaelli E; Miranda C; Vizioli MG; Pagliardini S; Favini E; Cleris L; Supino R; Formelli F; Borrello MG; Pierotti MA; Greco A
    Oncogene; 2011 Jul; 30(27):3011-23. PubMed ID: 21339735
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Regression does not predict nodal metastasis or survival in patients with cutaneous melanoma.
    Burton AL; Gilbert J; Farmer RW; Stromberg AJ; Hagendoorn L; Ross MI; Martin RC; McMasters KM; Scoggins CR; Callender GG
    Am Surg; 2011 Aug; 77(8):1009-13. PubMed ID: 21944515
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Novel role for RGS1 in melanoma progression.
    Rangel J; Nosrati M; Leong SP; Haqq C; Miller JR; Sagebiel RW; Kashani-Sabet M
    Am J Surg Pathol; 2008 Aug; 32(8):1207-12. PubMed ID: 18580492
    [TBL] [Abstract][Full Text] [Related]  

  • 18. E- to N-cadherin switch in melanoma is associated with decreased expression of phosphatase and tensin homolog and cancer progression.
    Lade-Keller J; Riber-Hansen R; Guldberg P; Schmidt H; Hamilton-Dutoit SJ; Steiniche T
    Br J Dermatol; 2013 Sep; 169(3):618-28. PubMed ID: 23662813
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinicopathological implications of tumour-associated macrophages and vascularization in sinonasal melanoma.
    Shi L; Lei D; Ma C; Xu F; Li Y; Wang Y; Cong N; Liu D; Pan XL
    J Int Med Res; 2010; 38(4):1276-86. PubMed ID: 20926000
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Alterations of the tissue inhibitor of metalloproteinase-3 (TIMP3) gene in pancreatic adenocarcinomas.
    Fendrich V; Slater EP; Heinmöller E; Ramaswamy A; Celik I; Nowak O; Chaloupka B; Gerdes B; Bartsch DK
    Pancreas; 2005 Mar; 30(2):e40-5. PubMed ID: 15714128
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.